SEC Form 5 · accession 0000950138-19-000062
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Martin Carroll
Director
Period of report
Dec 28, 2018
Accepted (ET)
Feb 5, 2019 · 8:05 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | May 31, 2018 | G | 20,487 | $0.00 | D | 19,438 | D | |
| Ordinary Shares | May 31, 2018 | G | 20,487 | $0.00 | A | 20,487 | I | By Spouse |
| Ordinary Shares | Jun 4, 2018 | G | 20,487 | $0.00 | D | 0 | I | By Spouse |
| Ordinary Shares | Jun 4, 2018 | G | 20,487 | $0.00 | A | 20,487 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 131 shares distributed in satisfaction of an annuity by the grantor retained annuity trust to the reporting person, which was exempt from reporting pursuant to Rule 16a-13.
Remarks
This Form 5 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014.